Previous article Commissioned Research: Moberg Pharma
Previous article Emerging Markets View: Thunderstruck – August 2018
We interview Karl Tobieson, CEO of Swedish listed life science group MedCap, on what the company considers its key focus for attracting investor interest, what triggered...
Previous article Commissioned Research: Suominen Oyj
Previous article Time for reflection: 18 months with Nordea On Your Mind
Nordea On Your Mind Article by: Martin Månsson How MiFID II regulation changes the playing field for both the buy-side and the sell-side in the securities...
Next article Interview: Sell-side research should move to a select-from-menu offering
Disclaimer and legal disclosures Origin of the report This report originates from: Nordea Bank AB (publ), including its branches Nordea Danmark, filial af Nordea Bank AB...
Disclaimer and legal disclosures Origin of the report This report originates from: Nordea Bank AB (publ), including its branches Nordea Danmark, filial af Nordea Bank AB...
Research Why a US recession isn’t just around the corner The recent flattening of the US yield curve has sparked fears of a looming US recession....